Patent ID: 11890292
Assignee: RESEARCH CANCER INSTITUTE OF AMERICA
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 9:
10. A method of treatment of a neoplasm in a patient in need thereof, the method comprising:
identifying a patient with a neoplasm;
administering a pharmaceutical composition comprising:
synergistically effective amounts of:
at least one anti-cancer agent, wherein the at least one anti-cancer agent is cyclophosphamide, and wherein the cyclophosphamide is administered orally at a dose of about 3 mg/kg to about 50 mg/kg;
a first anti-cancer response modulator, wherein the first anti-cancer response modulator is intravenous quercetin; and
a second anti anti-cancer response modulator, wherein the second anti-cancer response modulator is intravenous SPB.